Proteome Sciences (LON:PRM) Trading 22.4% Higher – What’s Next?

Proteome Sciences plc (LON:PRM) shares traded up 22.4% on Wednesday . The stock traded as high as GBX 3 and last traded at GBX 2.76. 472,430 shares were traded during mid-day trading, an increase of 99% from the average session volume of 237,921 shares. The stock had previously closed at GBX 2.26.

Proteome Sciences Stock Up 10.9%

The firm has a market cap of £7.38 million, a price-to-earnings ratio of -2.21 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The firm has a fifty day moving average price of GBX 1.99 and a 200-day moving average price of GBX 2.55.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.